F Dx Advisors, Inc. Astrazeneca PLC Transaction History
F Dx Advisors, Inc.
- $327 Million
- Q2 2025
A detailed history of F Dx Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, F Dx Advisors, Inc. holds 7,537 shares of AZN stock, worth $621,048. This represents 0.16% of its overall portfolio holdings.
Number of Shares
7,537
Previous 11,420
34.0%
Holding current value
$621,048
Previous $839,000
37.19%
% of portfolio
0.16%
Previous 0.27%
Shares
35 transactions
Others Institutions Holding AZN
# of Institutions
1,451Shares Held
489MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.28 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.39 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.83 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.59 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.57 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $255B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...